A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals a new signaling mechanism ...

Pseudoscience has recently re-emerged in the U.S. While much of it concerns vaccines, an "oldie" is again making the rounds: ...

Statistics from the district health department indicate that in 2023, suspected cases of sickle cells stood at 1,456 and in 2024, the registered cases were 914. Thank you for reading Nation.Africa ...

Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.

Over the past decades, understanding and treating HIV infection has advanced tremendously. This year the drug lenacapavir, which blocks release of the viral genome in the cell and effectively ...

Along with the amplification of HPV and cell division, resulting in a large number ... could make cervical cancer cells more susceptible to HIV and facilitating a potential vicious cycle of ...

Knowing the risks of each cycle equips you to avoid them. In the accumulation phase, the market has bottomed, and early adopters and contrarians see an opportunity to scoop up bargains.

HIV-1, like other viruses, lacks the machinery to produce its own proteins and must rely on the host cell to translate its genetic instructions. After entering host cells, it seizes control of the ...

According to precedent and due to his status, Yoon will probably be assigned a solitary cell, likely bigger and better appointed than the standard 6.56 square metre (71 square feet) single cells.

Mesoblast shares fall ~7% after a $260 million placement following FDA approval for its cell therapy treatment remestemcel-L in December Atomo Diagnostics inks a five-year $5.44 million deal with ...

Record temperatures last year pushed the global water cycle to “new climatic extremes,” according to the Global Water Monitor 2024 report. The document, produced by an international consortium ...